MET Overexpression and Amplification Define a Distinct Molecular Subgroup for Targeted Therapies in Gastric Cancer

Authors :: Xia Sun
Nandie Wu
Jie Shen
Juan Du
Zihan Lin
Baorui Liu
Jia Wei
Source :: Journal of Clinical Oncology. 33:e15076-e15076
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.
Abstract: e15076 Background: Gastric cancer is among the leading causes of cancer deaths. Currently, only trastuzumab, ramucirumab, and lapatinib effectively treat gastric cancer. Thus, additional novel targ...

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
business.industry
digestive, oral, and skin physiology
Cancer
Lapatinib
medicine.disease
digestive system diseases
Ramucirumab
Causes of cancer
Trastuzumab
Internal medicine
medicine
skin and connective tissue diseases
business
medicine.drug

Tools